• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病与骨质疏松症共享基因的综合分析。

Integrated analysis of genes shared between type 2 diabetes mellitus and osteoporosis.

作者信息

Li Fangyu, Wang Ying, Cao Jie, Chen Qi, Gao Yuanyuan, Li Rui, Yuan Li

机构信息

Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Pharmacol. 2024 Jun 20;15:1388205. doi: 10.3389/fphar.2024.1388205. eCollection 2024.

DOI:10.3389/fphar.2024.1388205
PMID:38966541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11222565/
Abstract

BACKGROUND

The relationship between type 2 diabetes mellitus (T2DM) and osteoporosis (OP) has been widely recognized in recent years, but the mechanism of interaction remains unknown. The aim of this study was to investigate the genetic features and signaling pathways that are shared between T2DM and OP.

METHODS

We analyzed the GSE76894 and GSE76895 datasets for T2DM and GSE56815 and GSE7429 for OP from the Gene Expression Omnibus (GEO) database to identify shared genes in T2DM and OP, and we constructed coexpression networks based on weighted gene coexpression network analysis (WGCNA). Shared genes were then further analyzed for functional pathway enrichment. We selected the best common biomarkers using the least absolute shrinkage and selection operator (LASSO) algorithm and validated the common biomarkers, followed by RT-PCR, immunofluorescence, Western blotting, and enzyme-linked immunosorbent assay (ELISA) to validate the expression of these hub genes in T2DM and OP mouse models and patients.

RESULTS

We found 8,506 and 2,030 DEGs in T2DM and OP, respectively. Four modules were identified as significant for T2DM and OP using WGCNA. A total of 19 genes overlapped with the strongest positive and negative modules of T2DM and OP. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed these genes may be involved in pantothenate and CoA biosynthesis and the glycosaminoglycan biosynthesis-chondroitin sulfate/dermatan sulfate and renin-angiotensin system signaling pathway. The LASSO algorithm calculates the six optimal common biomarkers. RT-PCR results show that , and were upregulated in T2DM and OP. Immunofluorescence and Western blot show that is upregulated in the pancreas and bones of T2DM model mice and osteoporosis model mice. Similarly, the level of in the sera of patients with T2DM, OP, and T2DM and OP was higher than that in the healthy group.

CONCLUSION

Based on the WGCNA and LASSO algorithms, we identified genes and pathways that were shared between T2DM and OP. Both pantothenate and CoA biosynthesis and the glycosaminoglycan biosynthesis-chondroitin sulfate/dermatan sulfate and renin-angiotensin systems may be associated with the pathogenesis of T2DM and OP. Moreover, may be a potential diagnostic marker for patients with T2DM complicated by OP. This study provides a new perspective for the systematic study of possible mechanisms of combined OP and T2DM.

摘要

背景

近年来,2型糖尿病(T2DM)与骨质疏松症(OP)之间的关系已得到广泛认可,但两者相互作用的机制仍不清楚。本研究旨在探讨T2DM和OP之间共享的遗传特征和信号通路。

方法

我们分析了来自基因表达综合数据库(GEO)的T2DM的GSE76894和GSE76895数据集以及OP的GSE56815和GSE7429数据集,以确定T2DM和OP中的共享基因,并基于加权基因共表达网络分析(WGCNA)构建共表达网络。然后对共享基因进行功能通路富集分析。我们使用最小绝对收缩和选择算子(LASSO)算法选择最佳的共同生物标志物,并对共同生物标志物进行验证,随后通过逆转录聚合酶链反应(RT-PCR)、免疫荧光、蛋白质免疫印迹和酶联免疫吸附测定(ELISA)来验证这些核心基因在T2DM和OP小鼠模型及患者中的表达。

结果

我们在T2DM和OP中分别发现了8506个和2030个差异表达基因(DEG)。使用WGCNA鉴定出四个对T2DM和OP具有显著意义的模块。共有19个基因与T2DM和OP的最强正、负模块重叠。京都基因与基因组百科全书(KEGG)分析表明,这些基因可能参与泛酸和辅酶A生物合成以及糖胺聚糖生物合成 - 硫酸软骨素/硫酸皮肤素和肾素 - 血管紧张素系统信号通路。LASSO算法计算出六个最佳的共同生物标志物。RT-PCR结果显示,[具体基因名称1]、[具体基因名称2]和[具体基因名称叁]在T2DM和OP中上调。免疫荧光和蛋白质免疫印迹显示,[具体基因名称肆]在T2DM模型小鼠和骨质疏松症模型小鼠的胰腺和骨骼中上调。同样,T2DM患者、OP患者以及T2DM合并OP患者血清中的[具体基因名称肆]水平高于健康组。

结论

基于WGCNA和LASSO算法,我们鉴定出了T2DM和OP之间共享的基因和通路。泛酸和辅酶A生物合成以及糖胺聚糖生物合成 - 硫酸软骨素/硫酸皮肤素和肾素 - 血管紧张素系统可能都与T2DM和OP的发病机制有关。此外,[具体基因名称肆]可能是T2DM合并OP患者的潜在诊断标志物。本研究为系统研究OP合并T2DM的可能机制提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/39201ae4abdf/fphar-15-1388205-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/a28f847aa419/fphar-15-1388205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/1418c426104f/fphar-15-1388205-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/d8c0b048cfcc/fphar-15-1388205-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/6849783fe2bd/fphar-15-1388205-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/3955fa75a03d/fphar-15-1388205-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/ff1a13423bd6/fphar-15-1388205-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/eedc1426eabe/fphar-15-1388205-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/866fba37ce48/fphar-15-1388205-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/39201ae4abdf/fphar-15-1388205-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/a28f847aa419/fphar-15-1388205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/1418c426104f/fphar-15-1388205-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/d8c0b048cfcc/fphar-15-1388205-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/6849783fe2bd/fphar-15-1388205-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/3955fa75a03d/fphar-15-1388205-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/ff1a13423bd6/fphar-15-1388205-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/eedc1426eabe/fphar-15-1388205-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/866fba37ce48/fphar-15-1388205-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/11222565/39201ae4abdf/fphar-15-1388205-g009.jpg

相似文献

1
Integrated analysis of genes shared between type 2 diabetes mellitus and osteoporosis.2型糖尿病与骨质疏松症共享基因的综合分析。
Front Pharmacol. 2024 Jun 20;15:1388205. doi: 10.3389/fphar.2024.1388205. eCollection 2024.
2
Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.骨质疏松症中 m6A 相关分子模式与诊断生物标志物的综合分析
Front Endocrinol (Lausanne). 2022 Aug 10;13:957742. doi: 10.3389/fendo.2022.957742. eCollection 2022.
3
Identification of osteoporosis ferroptosis-related markers and potential therapeutic compounds based on bioinformatics methods and molecular docking technology.基于生物信息学方法和分子对接技术鉴定骨质疏松症铁死亡相关标志物和潜在治疗化合物。
BMC Med Genomics. 2024 Apr 22;17(1):99. doi: 10.1186/s12920-024-01872-0.
4
Prognostic analysis and validation of diagnostic marker genes in patients with osteoporosis.骨质疏松症患者诊断标志物基因的预后分析与验证。
Front Immunol. 2022 Oct 13;13:987937. doi: 10.3389/fimmu.2022.987937. eCollection 2022.
5
Identification of a Potential MiRNA-mRNA Regulatory Network for Osteoporosis by Using Bioinformatics Methods: A Retrospective Study Based on the Gene Expression Omnibus Database.基于基因表达综合数据库的生物信息学方法鉴定骨质疏松症潜在的 miRNA-mRNA 调控网络:一项回顾性研究。
Front Endocrinol (Lausanne). 2022 May 10;13:844218. doi: 10.3389/fendo.2022.844218. eCollection 2022.
6
SIRT1 and ZNF350 as novel biomarkers for osteoporosis: a bioinformatics analysis and experimental validation.SIRT1 和 ZNF350 作为骨质疏松症的新型生物标志物:生物信息学分析和实验验证。
Mol Biol Rep. 2024 Apr 18;51(1):530. doi: 10.1007/s11033-024-09406-8.
7
Exploring the shared gene signatures of smoking-related osteoporosis and chronic obstructive pulmonary disease using machine learning algorithms.使用机器学习算法探索吸烟相关骨质疏松症和慢性阻塞性肺疾病的共享基因特征。
Front Mol Biosci. 2023 May 11;10:1204031. doi: 10.3389/fmolb.2023.1204031. eCollection 2023.
8
Identification of metabolism genes related to hepatocarcinogenesis and progression in type 2 diabetes mellitus via co-expression networks analysis.通过共表达网络分析鉴定 2 型糖尿病肝癌发生和进展相关的代谢基因。
Hereditas. 2021 Apr 17;158(1):14. doi: 10.1186/s41065-021-00177-x.
9
Six potential biomarkers in septic shock: a deep bioinformatics and prospective observational study.脓毒性休克的 6 个潜在生物标志物:一项深入的生物信息学和前瞻性观察研究。
Front Immunol. 2023 Jun 8;14:1184700. doi: 10.3389/fimmu.2023.1184700. eCollection 2023.
10
Identification of Potential Biomarkers of Type 2 Diabetes Mellitus-Related Immune Infiltration Using Weighted Gene Coexpression Network Analysis.使用加权基因共表达网络分析鉴定 2 型糖尿病相关免疫浸润的潜在生物标志物。
Biomed Res Int. 2022 Feb 9;2022:9920744. doi: 10.1155/2022/9920744. eCollection 2022.

引用本文的文献

1
Identification of retinol dehydrogenase 10 as a shared biomarker for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus.视黄醇脱氢酶10作为代谢功能障碍相关脂肪性肝病和2型糖尿病共同生物标志物的鉴定。
Front Pharmacol. 2025 Jan 24;16:1521416. doi: 10.3389/fphar.2025.1521416. eCollection 2025.
2
The impact of diabetes mellitus on tendon pathology: a review.糖尿病对肌腱病理的影响:综述
Front Pharmacol. 2024 Nov 5;15:1491633. doi: 10.3389/fphar.2024.1491633. eCollection 2024.

本文引用的文献

1
The Relationship between Renin-Angiotensin-Aldosterone System (RAAS) Activity, Osteoporosis and Estrogen Deficiency in Type 2 Diabetes.2 型糖尿病中肾素-血管紧张素-醛固酮系统 (RAAS) 活性、骨质疏松症与雌激素缺乏的关系。
Int J Mol Sci. 2023 Jul 26;24(15):11963. doi: 10.3390/ijms241511963.
2
Femoral bone mineral density at the time of hip fracture is higher in women with versus without type 2 diabetes mellitus: a cross-sectional study.髋部骨折时股骨骨密度在 2 型糖尿病女性中高于无 2 型糖尿病女性:一项横断面研究。
J Endocrinol Invest. 2024 Jan;47(1):59-66. doi: 10.1007/s40618-023-02122-3. Epub 2023 Jun 10.
3
Intestinal ACE2 regulates glucose metabolism in diet-induced obese mice through a novel gut-islet axis mediated by tryptophan.
肠道ACE2通过由色氨酸介导的新型肠-胰岛轴调节饮食诱导肥胖小鼠的葡萄糖代谢。
Obesity (Silver Spring). 2023 May;31(5):1311-1325. doi: 10.1002/oby.23719. Epub 2023 Mar 30.
4
Exploration of the shared pathways and common biomarker PAN3 in ankylosing spondylitis and ulcerative colitis using integrated bioinformatics analysis.采用综合生物信息学分析方法探讨强直性脊柱炎和溃疡性结肠炎的共同途径和共同生物标志物 PAN3。
Front Immunol. 2023 Jan 18;14:1089622. doi: 10.3389/fimmu.2023.1089622. eCollection 2023.
5
Identification of FGF13 as a Potential Biomarker and Target for Diagnosis of Impaired Glucose Tolerance.鉴定成纤维细胞生长因子 13 作为潜在的生物标志物和诊断葡萄糖耐量受损的靶标。
Int J Mol Sci. 2023 Jan 16;24(2):1807. doi: 10.3390/ijms24021807.
6
Risk assessment tools for osteoporosis and fractures in 2022.2022年骨质疏松症和骨折的风险评估工具
Best Pract Res Clin Rheumatol. 2022 Sep;36(3):101775. doi: 10.1016/j.berh.2022.101775. Epub 2022 Aug 29.
7
Assessment and treatment of osteoporosis and fractures in type 2 diabetes.2型糖尿病患者骨质疏松症及骨折的评估与治疗
Trends Endocrinol Metab. 2022 May;33(5):333-344. doi: 10.1016/j.tem.2022.02.006. Epub 2022 Mar 17.
8
Bone fragility in diabetes: novel concepts and clinical implications.糖尿病中的骨脆性:新概念与临床意义
Lancet Diabetes Endocrinol. 2022 Mar;10(3):207-220. doi: 10.1016/S2213-8587(21)00347-8. Epub 2022 Jan 31.
9
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2021 年全球、区域和国家糖尿病患病率估算值以及 2045 年预测值。
Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6.
10
Update on Osteoporosis Screening and Management.骨质疏松症筛查和管理的最新进展。
Med Clin North Am. 2021 Nov;105(6):1117-1134. doi: 10.1016/j.mcna.2021.05.016. Epub 2021 Sep 8.